Article Details

Giddy up: Alexion challenger Apellis could race to $4B in annual sales with Empaveli ...

Retrieved on: 2021-08-19 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Giddy up: Alexion challenger Apellis could race to $4B in annual sales with Empaveli .... View article details on hiswai:

Excerpt

That's high talk for little Apellis, which is going toe-to-toe with industry heavyweights like Alexion's Soliris and its follow-up Ultomiris with ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up